Back to Journals » Cancer Management and Research » Volume 12

Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial

Total article views   Abstract views HTML views PDF downloads Totals
1,600 Dovepress* 1,349 153+ 386 1,502
PubMed Central* 0 98 22 98
Totals 1,349 251 408 1,600
*Since 17 June 2020
+Since July 2016

View citations on PubMed Central and Google Scholar